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ABSTRACT
Objective: To develop measures of the day-to-day symptomatic and func-
tional impact of recurrent genital herpes (RGH) outbreaks. The Herpes
Outbreak Impact Questionnaire (HOIQ) and the Herpes Symptom Check-
list (HSC) were designed to be acceptable to clinical professionals and to
reﬂect patients’ experience.
Methods: Scale content was derived via literature review and interviews
with RGH patients and physicians. Questionnaires were assessed for face/
content validity in the UK and the language checked for acceptability in the
United States. The USmeasures were assessed for face/content validity with
patients. Scaling/psychometric properties were determined via web survey.
Participants completed the questionnaires twice during an outbreak, with
24 to 72 hours between administrations.
Results: Respondents found the questionnaires relevant and easy to
understand and complete. Application of Rasch analysis resulted
in the removal of two HOIQ items. Both scales were found to be uni-
dimensional. Item stability testing for the HOIQ indicated that the
measure is reproducible. Internal consistency was good (alpha: time
1 = 0.87, time 2 = 0.91). Discriminative validity was demonstrated by
the measure’s ability to distinguish between individuals who differed by
self-reported severity of outbreak. The HOIQ and HSC were both
responsive to change over time.
Conclusions: The HSC and the HOIQ can determine the impact of a
herpes outbreak effectively. They are designed to be used daily during such
outbreaks and to determine the effectiveness of RGH treatment.
Keywords: functioning, patient reported outcome, questionnaire, recur-
rent genital herpes, symptoms.
Introduction
Genital herpes is one of the most common viral sexually trans-
mitted diseases, affecting millions of people worldwide [1]. It is
caused by infection with the herpes simplex virus HSV-1 (the
form more commonly associated with orolabial lesions) or
HSV-2 (traditionally associated with sexually acquired anogeni-
tal lesions) [2,3]. The condition is thought to be prevalent in all
sexually active populations, with rates rising in adolescents with
a peak in 20- to 29-year olds [4,5].
For many infected individuals, the condition is benign and
self-limiting; up to three quarters experience no, or very mild,
symptoms and may be unaware that they have the disease [6].
Nevertheless, the remainder experience recurrent outbreaks of
symptoms that can vary in severity and duration. Patients experi-
encing recurrent genital herpes (RGH) experience an average of
four to six episodes a year, although up to one-third of patients
report in excess of 10 episodes [7,8]. Recurrent episodes are
typically characterized by a period of prodromal symptoms
(itching, tingling, inﬂammation and localized pain along with
general ﬂu-like symptoms) followed by emergence of genital sores
or ulcers that may take up to six days to heal [8,9]. Frequency and
severity of recurrences may diminish naturally over time and
current treatments can result in a reduction in the number or
severity of outbreaks or reduce viral shedding. Nevertheless, no
cure exists and many individuals continue to experience distress-
ing and painful outbreaks for much of their adult life [10].
The impact of RGH on the quality of life (QoL) of affected
individuals has been well documented [8,11]. Uncertainty sur-
rounding frequency and severity of outbreaks and the perceived
stigma attached to having a sexually acquired infection has a
profound impact on personal relationships, feelings of sexual
desirability, sexual activity, mood, well-being and, ultimately,
self-esteem [11,12]. Fear of forming relationships and of rejec-
tion may affect the capacity for expressing physical warmth and
intimacy and the enjoyment of sex. The disorder may also lead to
a loss of sexual conﬁdence and adversely affect feelings of sexual
desirability [13].
Although many studies have focused on the long-term
psychological impact of RGH, limited information is available
on the experience of herpes outbreaks and no measures
speciﬁc to day-to-day impact exist. The Recurrent Genital
Herpes QoL Questionnaire (RGHQoL) [14] has been shown
to be highly responsive to changes in QoL associated with
antiviral treatment [7]. Nevertheless, this measure is designed
to be used between outbreaks and is concerned with longer-
term issues related to the impact of the disease and its
treatment on the patient. During herpes outbreaks, the patient
is likely to be concerned with more immediate impacts,
such as pain or restrictions in social and work activities. Such
factors are related to impairment and functioning rather than
QoL.
The purpose of this study was to develop instruments to
measure day-to-day symptomatology and functioning that are
speciﬁc to genital herpes outbreaks. Two complementary instru-
ments were developed; the Herpes Symptom Checklist (HSC) to
assess daily symptoms and theHerpesOutbreak ImpactQuestion-
naire (HOIQ) to measure day-to-day functional impact of out-
breaks. Both instruments were designed to:
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1 Be easy to administer;
2 Be acceptable to clinical professionals;
3 Reﬂect the experience of RGH patients;
4 Have good psychometric properties (speciﬁcally; unidimen-
sionality, reliability and validity).
Because the instruments were initially required to establish
the effectiveness of antiviral therapies during the course of an
outbreak, there was a speciﬁc need for the scales to be responsive
to change in impact over a short period of time. The measures are
intended to be used during actual outbreaks only.
Methods
Study Participants
Patients involved in all stages of the research were required to
meet the following inclusion/exclusion criteria:
Inclusion criteria
1 18 years of age or older;
2 Established RGH;
3 One or more of the following should also apply:
• Experiencing three or more herpes outbreaks a year,
with RGH duration of 12 months or more.
• If experiencing fewer than three outbreaks per year,
patients should have had RGH for at least 12 months
and currently be on suppression treatment, providing
that they had experienced an outbreak frequency of
three or more occurrences a year before suppression.
• If they had RGH for less than a year, patients must
have had herpes for at least 6 months and have expe-
rienced more than three outbreaks in that time.
Exclusion criteria. Patients with any major co-morbidity consid-
ered likely to inﬂuence their responses to the questionnaires.
Generation of Content for the New Questionnaires
The methodology employed was designed to generate question-
naire items while checking that issues considered important by
clinical experts were not omitted from the ﬁnal measures. Three
methods were used to generate questionnaire content; interviews
with patients, a literature review and interviews with clinical
experts.
Interviews with RGH patients. Interviews were conducted with
25 RGH patients recruited through Genitourinary Departments
in the UK. Emphasis during the interviews was placed on the
actual herpes outbreak with respondents encouraged to describe
in detail the symptoms they experienced and the way in which
their social, emotional and physical functioning was impaired.
The interviews were audio-recorded and full transcripts
produced.
To supplement these interviews, the researchers had access to
15 transcripts of interviews conducted with RGH patients as part
of the development of the RGHQoL during the early 1990s [14].
These interviews included patient reports of symptoms and func-
tioning arising from herpes outbreaks.
The transcripts from both sets of interviews were subjected to
thematic analysis to identify key areas of impact. Analysis was
conducted independently by three experienced researchers and
their ﬁndings compared. Issues related to symptoms or function-
ing were identiﬁed and recorded.
Review of the literature. A literature review was undertaken to
identify any additional information on the symptomatic or func-
tional impact of RGH. Findings from the review were compared
with the results of the analysis of patient interviews to ensure that
no areas had been missed.
Interviews with clinical experts. Interviews were conducted with
three clinical experts employed in Genitourinary Departments in
the UK who specialized in treating sexually transmitted diseases.
They were asked to review the list of symptoms and functional
problems generated after the analysis of patient interviews and
review of the literature to identify whether any issues of impor-
tance had been omitted.
Draft measures were designed using, as far as possible, the
wording/phrasing used by interviewees.
Cognitive Debrieﬁng Interviews
Interviews were conducted with 12 patients in the UK to assess
the face and content validity of the draft questionnaires. Inter-
viewees were asked to complete the questionnaire in the presence
of the interviewer and then to comment on the suitability and
acceptability of the content. They were also asked to indicate
whether any important issues had been omitted.
Production of US-English Versions of Scales
The ﬁrst requirement for use of the measures was in the United
States. To ensure that the instruments were appropriate for use in
the United States, the UK content was adapted to US English by
a lay panel held in the United States. Emphasis was placed on
ensuring that the wording selected was appropriate for the local
population. Cognitive debrieﬁng interviews were then conducted
with nine RGH patients in North Carolina to ensure the face and
content validity of the US measures using the same methodology
as above.
The following stages of the study tested the psychometric
properties of the US version of the scales, including unidimen-
sionality, reliability and construct validity.
Assessment of Scaling and Traditional
Psychometric Properties
A web survey was conducted to assess the scaling and psycho-
metric properties of the draft scales via the Antopia Web site,
http://www.MPwH.net. Antopia is an Internet-based organiza-
tion providing social resources, support and information for
people living with herpes.
Both the HSC and HOIQ were completed together with a
brief demographic questionnaire. The latter also included ques-
tions on RGH history and perceived general well-being and
severity of RGH.
Only members of MPwH who paid for upgraded services
were able to complete the survey. Interested respondents were
required to complete screening questions to ensure that they met
the eligibility criteria before completing the HSC and HOIQ. An
automated online program was devised to ensure that eligible
subscribers could complete only one set of responses.
Potential responders were asked to complete the question-
naires on two occasions: on the ﬁrst day of a herpes outbreak and
again 2 days later. Respondents who completed the second set of
questionnaires fewer than 24 or more than 72 hours after com-
pleting the ﬁrst were excluded from the study.
Scaling assessment. Rasch analyses were conducted on the
survey data to assess the scaling properties of the HOIQ. The
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Rasch model [15] utilized is the one-parameter logistic item
response theory model that is most widely used in health
outcome measurement. Analyses were conducted using the Rasch
Unidimensional Measurement Model (RUMM2010) software
[16] adopting the unrestricted partial credit model.
The adequacy of the ﬁt to the model was evaluated through a
total chi-square (c2) ﬁt statistic. In addition, the ﬁt of the indi-
vidual itemswas evaluated through individual item c2 ﬁt statistics.
A statistically signiﬁcantc2 is taken to indicate inadequate ﬁt to the
model. Given the number of tests applied, a 95% signiﬁcance level
would not normally be considered appropriate. Thus, ﬁt values
below 0.01 were taken to indicate misﬁt and those between 0.01
and 0.05 were taken as indicating borderline misﬁt. Further
information on the consistency of the pattern of responses to
individual items was provided by standardized residuals
([observed score - expected score]/standard error). Residuals
within the range 2.5 to -2.5 were taken as indicating adequate
consistency. Items that signiﬁcantly misﬁt or had excessive residu-
als were considered candidates for removal in the item reduction
process.
The logit and person coverage of the HOIQ was examined
using the item map of uncentralized thresholds and the person–
location distribution map. This informs on the scope of the
underlying construct covered by the scales.
Rasch analysis was also used to assess unidimensionality of
the HSC. Conﬁrmation of unidimensionality allows item scores
to be summed to produce a single-scale score.
Traditional psychometric analyses. Having identiﬁed the ﬁnal
item set for theHOIQ, traditional psychometric tests were applied
to the survey data. These included assessment of internal consis-
tency (Cronbach’s alpha coefﬁcients) and construct validity.
The assessment of test–retest reliability was not possible
because of the rapid changes that occur with the healing of lesions.
Instead, item stability was assessed by examining differential item
functioning (DIF; see [17,18] for more details) within the Rasch
framework. Survey data were analysed to determine whether DIF
occurred by questionnaire administration time. For a measure to
be reliable, the ordering of items (in terms of severity) should be
the same each time the questionnaire is administered and there
should be no DIF according to administration.
In addition to ﬁt to the Rasch model, construct validity was
evaluated by assessing the level of association between scores on
the HOIQ and those from the HSC. HOIQ scores were corre-
lated with HSC scores using nonparametric Spearman rank cor-
relation coefﬁcients. The HOIQ was expected to show moderate
association with the HSC because they measure related but dis-
tinct constructs.
Discriminative validity was assessed by testing the ability of
the measures to distinguish between groups of individuals that
differed according to some known factor. The factors used for
both scales were: patient-perceived severity of current and typical
outbreak (mild, moderate, quite severe or very severe) and
average duration of outbreaks (days). Non-parametric tests for
independent samples (Mann–Whitney U-test for two groups or
Kruskal–Wallis One-way Analysis of Variance for three or more
groups) were employed to test for differences in scale scores
between groups.
Because responsiveness was a crucial requirement of the mea-
sures, it was necessary to show that they were capable of dem-
onstrating improvements with time since start of outbreak. It was
hypothesized that scores on both measures would be lower (indi-
cating an improvement in symptomatic and functional impact)
on day 3 than day 1.
Results
Sample Details
Table 1 shows demographic characteristics of participants at
each stage of the study. Information on mean number and dura-
tion of outbreaks was not collected for US ﬁeld-test participants.
Nevertheless, all had experienced an outbreak within the previ-
ous 2 months. Participants who completed the Internet-based
survey also provided information on the perceived severity of
their current and typical outbreaks (Table 2).
Generation of Questionnaire Content
The following activities were affected or avoided:
• Social activities. Respondents reported avoiding places or
activities where they might become too hot during out-
breaks.
• Sporting activities. For example, interviewees would return
home to shower rather than using facilities at the sports
center.
• Work. Some interviewees reported being unable to attend
work because of difﬁculty sitting, feeling generally ill or
because of a constant urge to run to the restroom to scratch.
Table 1 Characteristics of study participants
UK Interview sample UK ﬁeld-test interviews US ﬁeld-test interviews US Web survey
Sample size 25 12 9 158
Number (%); men 8 (32) 3 (25) 4 (44.4) 76 (47.1)
Number (%); women 17 (68) 9 (75) 5 (55.6) 82 (51.9)
Mean (SD) age; years 40.9 (10.1) 40.5 (8.0) 39.0 (7.5) 35.8 (7.6)
Age range; years 18.0–65.0 31.0–55.0 27.0–49.0 19.0–59.0
Number (%) employed 18 (72) 9 (75) 137 (86.7)
Mean (SD) duration of herpes; years 11.9 (6.2) 12.7 (5.1) 6.9 (7.1) 8.6 (7.3)
Duration range; years 2.5–23.0 5.5–20.0 0.33–21.0 0.5–30.0
Mean (SD) number of outbreaks per year 7.8 (6.8) 6.2 (3.3) 5.3 (3.2)
Mean (SD) duration of outbreaks; days 8.4 (4.6) 7.1 (4.8) 6.4 (3.9)
SD, standard deviation.
Table 2 Severity of outbreaks for Web survey participants (n = 158)
Severity of current
outbreak (%)
Severity of typical
outbreak (%)
Mild 98 (62.0) 76 (48.1)
Moderate 56 (35.4) 72 (45.6)
Quite severe 4 (2.5) 9 (5.7)
Very severe 0 (0.0) 1 (0.6)
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• Intercourse and other intimate contact (including hugging
or kissing) that could potentially lead to intercourse.
• Personal hygiene activities that would increase discomfort
or pain––e.g., use of soap was kept to a minimum.
• Some patients washed more frequently because they felt
unclean.
• Interviewees reported delaying urinating until absolutely
necessary.
• Avoidance of clothing that caused friction. Some respon-
dents chose not to wear underwear during an outbreak or
avoided tight jeans or trousers.
• Avoidance of foods (including chocolate and garlic) per-
ceived to exacerbate outbreaks.
• Avoidance of tiring activities. Respondents reported trying
to take things easier, taking more rest and avoiding late
nights.
In addition, many interviewees expressed feeling worried or
anxious during an outbreak: either because of concern about
potentially passing on the condition or to fear of discovery.
The literature review failed to identify additional impair-
ments or disabilities associated with outbreaks of RGH.
After checking the relevance and the frequency with which
both symptomatic and functional issues had been raised by inter-
viewees, the areas of impact were presented to three clinical
specialists. These individuals supported the ﬁndings from the
patient interviews.
Production of Draft Questionnaires
Draft versions of the HSC (13 items) and the HOIQ (14 items)
were produced. For the HSC, a 4-point severity response scale
(none, mild, moderate, and severe) was employed to rate pres-
ence and severity of symptoms on the day of completion. The
HOIQ also employed a 4-point response scale (not at all, a little,
a lot, very much).
Cognitive debrieﬁng interviews conducted with patients in
the UK revealed that the questionnaires were well accepted.
Respondents reported little difﬁculty completing the scales and
considered the content to be appropriate.
Production of US versions of the scales. Most of the language
was considered appropriate for use in the United States. Minor
changes were made to the HSC. For example, for the symptom
crusts, it was considered necessary to follow this with the term
scabs in parentheses for US respondents. Similarly, minor
changes were made to several items in the HOIQ, largely to
replace Anglicized spelling with Americanized versions (for
example, replacing socialising with socializing). It was also sug-
gested that the last two response options for the HOIQ be
changed to “A fair amount” and “A great deal.”
Cognitive debrieﬁng interviews conducted with patients in
the United States revealed that they were able to understand the
questionnaire’s instructions and items without any difﬁculty. The
instructions and response scales were easily understood and
accepted by all participants and the language employed was
considered appropriate for use in the United States.
Assessment of Scaling and Traditional
Psychometric Properties
The survey included 158 participants and the average time
between administrations of the questionnaires was 2.1 (standard
deviation, SD = 0.3) days.
Scaling assessment. The 13-item HSC displayed good ﬁt to the
Rasch model. The overall c2 probability was nonsigniﬁcant
(P-value = 0.072), indicating an adequate ﬁt of the data to the
model. The item ﬁt statistic (mean = -0.16; SD = 1.15) and
person ﬁt statistic (mean = -0.20; SD = 0.82) also indicated
adequate ﬁt. This suggests that the HSC forms a unidimensional
scale. Item ﬁt statistics for the HSC are shown in Table 3.
The 14-item HOIQ exhibited signiﬁcant misﬁt to the Rasch
model (item-trait c2 P-value < 0.000). Assessment of the thresh-
old ordering was not conclusive because there was a low afﬁr-
mation of certain response categories as a result of the sample
being mild to moderate. Nevertheless, two misﬁtting items were
deleted (one at a time with the analyses re-run after each dele-
tion) and several more were rescored. The rescoring (collapsing
of categories) was necessary because an insufﬁcient number of
people had selected the severe categories. The remaining 12 items
ﬁt the Rasch model (item-trait c2 P-value = 0.34; item ﬁt statistic
mean = 0.17, SD = 1.36; person ﬁt statistic mean = 0.12,
SD = 0.88). The ﬁnal item ﬁt statistics for the HOIQ are shown
in Table 4. The item locations indicated that the mildest item
(representing the lowest level of underlying construct) is the item
“has your outbreak reduced your interest in sex?” (loca-
tion = -2.06) and the most severe item is “has your outbreak
made daily transportation uncomfortable for you?” (loca-
tion = 1.71). The item–person threshold distribution (Fig. 1)
indicated that the HOIQ items had good coverage of the under-
lying construct of activity limitation. No items exhibited signiﬁ-
cant DIF by administration (P-value  0.01) conﬁrming the
reproducibility (reliability) of the scale.
Traditional psychometric properties. The overall score for
the 13-item HSC is obtained by summing the scores for the
Table 3 Item ﬁt statistics for the Herpes Symptom Checklist
Item Location Standard error Residual c2 Probability
1 -0.81 0.10 2.21 11.27 0.01
2 -0.40 0.10 -1.01 1.05 0.79
3 -0.53 0.10 -0.73 7.84 0.05
4 -0.51 0.09 -1.55 4.04 0.26
5 -1.10 0.15 0.68 0.68 0.88
6 -0.98 0.09 -2.07 4.52 0.21
7 0.91 0.16 0.49 0.56 0.91
8 1.03 0.25 0.88 4.69 0.20
9 0.85 0.17 -0.89 2.85 0.42
10 -0.13 0.10 -0.30 9.15 0.03
11 -0.86 0.09 0.57 2.53 0.47
12 0.55 0.15 0.18 1.38 0.71
13 1.97 0.28 -0.50 1.95 0.58
Table 4 Final item ﬁt statistics for the Herpes Outbreak Impact
Questionnaire
Item Location Standard error Residual c2 Probability
1 0.10 0.10 -0.47 3.50 0.32
2 0.58 0.11 0.19 0.78 0.85
3 0.33 0.12 0.92 3.08 0.38
4 1.71 0.14 -1.14 2.05 0.56
5 -0.69 0.09 -0.23 1.74 0.63
7 0.53 0.18 -0.37 2.13 0.55
8 -0.23 0.09 0.78 2.06 0.56
9 -0.52 0.12 2.54 8.70 0.03
10 0.28 0.12 -1.16 2.63 0.45
12 -0.37 0.12 -1.59 8.17 0.04
13 -2.06 0.11 0.47 3.26 0.35
14 0.34 0.12 0.01 0.77 0.86
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individual symptoms (0–3), giving a possible maximum score of
39. The total score for the 12-item HOIQ is also obtained by
summing the scores for the individual items (0–3), giving a
maximum potential score of 36. In both cases, a high score
indicates greater impact.
Table 5 shows the score statistics for the instruments at each
time point. There was a signiﬁcant decrease in score over time for
both the HSC (effect size = 0.50) and the HOIQ (effect
size = 0.29), suggest ing that the scales are sensitive to changes
that occur during the genital herpes outbreak cycle.
The Cronbach alpha statistic for the HSC was 0.83 at time 1
and 0.84 at time 2 and for the HOIQ, 0.87 at time 1 and 0.91 at
time 2 (n = 158 at both administrations). This conﬁrms the inter-
nal consistency of the scales. Corrected item–total correlations
for HSC and HOIQ scale items were all >0.2 and <0.8, suggest-
ing that all items contribute adequately to their respective scales
without being redundant.
Correlations between the HSC and the HOIQ provided evi-
dence of convergent validity. Observed correlations were 0.60 at
time 1 and 0.67 at time 2, conﬁrming expectations that the two
scales measure related but distinct constructs.
Differences in scores were examined for people who differed
according to the duration of their typical outbreak and self-
reported severity of their current and typical outbreaks (Table 6).
Because of the small number of people who self-reported either
their current or typical outbreak severity as being quite or very
severe, these categories were combined with the moderate cat-
egory to make a single “moderate–severe” group.
As expected, it was shown that individuals who generally had
outbreaks of shorter duration scored signiﬁcantly lower on both
scales at time 2 but not at time 1, suggesting that lesions had
healed quicker.
Both the HSC and HOIQ were shown to discriminate
between individuals based on how severe they rated their current
or typical herpes outbreaks. The more severe the ratings of the
outbreak, the higher the score on the outcome measures.
There were no signiﬁcant differences in HSC or HOIQ scores
at either time point between people who differed according to
time with RGH (above and below the median of 7 years), age
(above and below the median age of 36 years) or employment
status (those who were and were not working). A signiﬁcant
difference was found between scores on the HSC according to sex
at time 1 (with women scoring signiﬁcantly higher than men).
Nevertheless, this difference was not present at time 2 for the
HSC or at either time point for the HOIQ.
Discussion
The RGHQoL questionnaire assesses the overall impact of the
infection on the individual’s QoL, focusing on the long-term
impacts of infection and treatment. Nevertheless, during an
Figure 1 Item–person threshold distribution for the Herpes Outbreak Impact Questionnaire.
Table 5 Herpes Symptom Checklist (HSC) and Herpes Outbreak Impact Questionnaire (HOIQ) scores at times 1 and 2
HSC (n = 158) HOIQ (n = 158)
Time 1 Time 2 P-value Time 1 Time 2 P-value
Mean score 8.7 5.8 0.000* 9.9 7.8 0.000*
Standard deviation 5.83 4.98 7.21 7.19
Median score 7.0 4.0 9.0 6.0
Score range 0.0–34.0 0.0–27.0 0.0–36.0 0.0–33.0
% scoring minimum 0.6 6.3 3.8 10.1
% scoring maximum 0.0 0.0 0.0 0.0
*Wilcoxon signed ranks test.
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outbreak a patient is likely to be more concerned with the symp-
toms of the actual outbreak (such as pain and discomfort) and
short-term limitations to social, work or other activities. Such
factors are related to impairment and functioning.
The HSC and the HOIQ are the ﬁrst instruments developed
to measure the impact of individual herpes outbreaks and use
items representing impairments and disabilities that were of spe-
ciﬁc importance to RGH patients. The measures were required to
be relevant and comprehensible to patients and to be unidimen-
sional, reliable, valid and easy to administer. They were designed
to be used alone or in conjunction with each other.
The instruments have been shown to be acceptable, relevant,
clear and understandable to respondents in both the UK and the
United States. The scaling and psychometric properties of the US
version of the questionnaires have been assessed. Item Response
Theory (the Rasch model) was employed to determine the uni-
dimensionality of the HOIQ and HSC. After removal of two
items, the HOIQ exhibited good ﬁt to the model, indicating that
the 12-item version is a unidimensional measure of functioning
during a herpes outbreak and that items may be validly summed
to obtain an overall score. The HOIQ items have good coverage
of the individuals assessed and the underlying construct, func-
tioning. The HSC data were shown to ﬁt the model without the
need for deletion of items.
The traditional psychometric testing of the HOIQ revealed
that the scale possesses good psychometric properties. Item sta-
bility of theHOIQ items indicated that none of the items exhibited
time-related DIF, indicating that the HOIQ is reproducible. The
measure was also shown to have good internal consistency. Cru-
cially, the HOIQ also displays evidence of construct validity in the
form of discriminative validity. At both time points, the HOIQ
was able to distinguish between individuals who differed accord-
ing to how severe they reported their outbreaks (both current and
typical) to be. The HSC also showed evidence of such validity.
The signiﬁcant decline in scale scores over the cycle of the
herpes outbreak (even though the administrations were only 2
days apart) also suggests that the HSC and HOIQ will be respon-
sive to changes in the impact of outbreaks over time. Both
measures have been included in a clinical trial that will provide
additional information on the responsiveness of the measures.
Future analyses of HOIQ and HSC data might also explore
whether DIF exists according to age and sex.
There were a number of limitations to the study. First,
because the study survey was Web-based, it represents a valida-
tion of only that mode of questionnaire administration. Never-
theless, there is evidence to suggest that Web-based surveys
provide results comparable to other modes of administration
[19,20] and the application of the HOIQ and HSC in a subse-
quent clinical trial showed that the pen and paper versions of the
questionnaires were reliable and valid. The mode of data collec-
tion for the validation survey may also have introduced sample
bias because it is known that the Internet is used by higher-
income, better-educated and younger individuals [21]. Neverthe-
less, analysis of HOIQ and HSC trial data collected from a clinic
indicates that the psychometric properties of the questionnaires
were comparable across samples. In addition, the Rasch analysis
indicated that some of the response option categories should be
collapsed; this may have been as a result of the sample being mild
and having a tendency to respond in the mild and moderate
response categories. Rasch analysis of HOIQ and HSC data from
more severe samples is required to determine whether the
response options are appropriate.
Although acknowledging these limitations, it is concluded
that the development of the HSC and HOIQ was successful and
that these new scales will prove to be valuable outcome measures
for use in clinical trials.
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Appendix
Example HOIQ Items
The following questions are intended to ﬁnd out how your
current herpes outbreak has affected you during the last 24
hours.
Please check one box only for each question.
Thinking about the last 24 hours:
has your outbreak Not at all A little
A fair
ount
A great
deal
Affected your interest in leisure
activities?
Made walking uncomfortable for
you?
Reduced your interest in social-
izing?
Affected the ount you washed
yourself?
Example HSC Items
Thinking about today. . . . Look down this list and, for each
problem, please put a tick in the box according to whether: You
have not had this problem (none), you have had this problem in
a mild form, you have had this problem in a moderate form, you
have had this problem and it was severe.
Have you had any of the following associated with your
outbreak today?
None Mild Moderate Severe
1 Tingling
2 Burning
3 Pain
4 Aching
5 Itching
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